公众对 COVID-19 疫苗全球分配的意见:来自德国和美国两项全国代表性调查的证据
2021年6月在美国(N=1,000)和德国(N=1,003)成年人群中开展代表性调查,用层次分析法(AHP)评估公众对疫苗分配原则的权重,并用离散选择实验让受访者在高收入与低收入国家间分配有限疫苗剂量。两国公众均更偏好功利主义和平等主义分配原则,而非自由意志主义或精英主义原则,提示有利于更高再分配水平的政治决策会得到这两国公众意见的支持。
要点
- AHP权重:美国「医疗紧迫性」37.4%、「所有人平等获取」32.7%;德国分别为49.4%和25.4%。
- 离散选择实验中,低收入国家(人口为高收入国家三倍)平均获得美国受访者分配的53.9%、德国受访者的57.5%疫苗剂量。
- 面临患病家属等待疫苗的困境时,美国20.7%、德国18.2%受访者减少分配给低收入国家的剂量以确保家属接种。
核心结论
- 美国与德国公众偏好功利主义和平等主义的 COVID-19 疫苗分配原则,而非自由意志主义或精英主义原则。
- 作者认为,有利于更高再分配水平的政治决策会得到这两国公众意见的支持。
研究设计与样本
- 2021年6月在美国(N=1,000)和德国(N=1,003)成年人群中开展代表性调查。
- 开展两项层次分析法(AHP)以了解公众对不同疫苗分配原则和标准的权重。
- 进一步采用离散选择实验,要求受访者在假设的高收入国家和假设的低收入国家之间分配有限疫苗剂量。
主要发现
- AHP权重(95%CI):美国「医疗紧迫性」37.4%(37.2-37.5)、「所有人平等获取」32.7%(32.6-32.8)、「生产贡献」13.7%(13.6-13.8)、「自由市场规则」16.3%(16.2-16.4)。
- AHP权重(95%CI):德国「医疗紧迫性」49.4%(49.2-49.5)、「所有人平等获取」25.4%(25.2-25.5)、「生产贡献」13.3%(13.2-13.4)、「自由市场规则」12.0%(11.9-12.1)。
- 离散选择实验中,低收入国家(人口为高收入国家三倍)平均获得美国受访者分配的53.9%(95%CI:52.6-55.1)和德国受访者分配的57.5%(95%CI:56.3-58.7)可用剂量。
- 面临患病家属等待疫苗的困境时,美国20.7%(95%CI:18.2-23.3)和德国18.2%(95%CI:15.8-20.6)受访者减少分配给低收入国家的剂量足以确保家属获得疫苗。
关键数值与推荐
- AHP评估的分配原则包括「医疗紧迫性」「所有人平等获取」「生产贡献」「自由市场规则」。
- 离散选择实验中低收入国家人口为高收入国家的三倍。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite ongoing calls for a more even global distribution of COVID-19 vaccines, there remains a great disparity between high- and low-income countries. We conducted representative surveys among the adult populations in the United States (N = 1,000) and Germany (N = 1,003) in June 2021 to assess public opinion in these countries on the distributive justice of COVID-19 vaccines. We conducted two instances of analytic hierarchy processes (AHP) to elicit how the public weighs different principles and criteria for vaccine allocation. In further discrete choice experiments, respondents were asked to split a limited supply of vaccine doses between a hypothetical high-income and a hypothetical low-income country. AHP weights in the United States and Germany were 37.4% (37.2-37.5) and 49.4% (49.2-49.5) for "medical urgency", 32.7% (32.6-32.8) and 25.4% (25.2-25.5) for "equal access for all", 13.7% (13.6-13.8) and 13.3% (13.2-13.4) for "production contribution", and 16.3% (16.2-16.4) and 12.0% (11.9-12.1) for "free market rules", respectively, with 95% CI shown in parentheses. In the discrete choice experiment, respondents in the United States and Germany split available vaccine doses such that the low-income country, which was three times more populous than the high-income country, on average received 53.9% (95% CI: 52.6-55.1) and 57.5% (95% CI: 56.3-58.7) of available doses, respectively. When faced with a dilemma where a vulnerable family member was waiting for a vaccine, 20.7% (95% CI: 18.2-23.3) of respondents in the United States and 18.2% (95% CI: 15.8-20.6) in Germany reduced the amount they allocated to the low-income country sufficiently to secure a vaccine for their family member. Our results indicate that the public in the United States and Germany favours utilitarian and egalitarian distribution principles of vaccines for COVID-19 over libertarian or meritocratic principles. This implies that political decisions favouring higher levels of redistribution would be supported by public opinion in these two countries.
引用
- Klumpp M, Monfared IG, Vollmer S, et al. Public opinion on global distribution of COVID-19 vaccines: Evidence from two nationally representative surveys in Germany and the United States. Vaccine. 2022. PMID: 35305827. doi:10.1016/j.vaccine.2022.02.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。